Effects of fermented soymilk with Lacticaseibacillus paracasei YIT 9029 on gut microbiota and defecation habits: a randomised, double-blind, placebo-controlled study
Authors:
Open Access
- 15 February 2024
- journal article
- research article
- Published by Walter de Gruyter GmbH in Beneficial Microbes
- Vol. 15 (2) , 127-143
Abstract
Previous studies have demonstrated that soymilk and Lacticaseibacillus paracasei YIT 9029 (strain Shirota: LcS) each beneficially affect the gut microbiota and defecation habits. To investigate the effects of daily consumption of fermented soymilk containing LcS (FSM), we conducted a randomised, double-blind, placebo-controlled study of 112 healthy Japanese adults with a low faecal Bifidobacterium count. They consumed 100 ml FSM or placebo (unfermented soymilk base) once daily for 4 weeks. Their gut microbiota was analysed by 16S rRNA gene amplicon sequencing and quantitative reverse transcription-polymerase chain reaction (PCR), and faecal short-chain fatty acids (SCFAs) and urinary putrefactive products were assessed during the pre- and post-consumption periods. Defecation habits were examined weekly using a subjective questionnaire. In the post-consumption period, living LcS were not detected in two subjects in the FSM group (n = 57) but were detected in one subject in the SM group (n = 55). The FSM group had a significantly higher number and relative abundance of faecal lactobacilli compared with the placebo group. The relative abundance of Bifidobacterium, alpha-diversity of microbiota, and concentrations of acetate and total SCFAs in faeces were significantly increased in the FSM group, although no significant differences were detected between the groups. The number of defecations and defecation days per week significantly increased in both groups. Subgroup analysis of 109 subjects, excluding 3 with inconsistent LcS detection (2 and 1 subjects in the FSM and SM groups, respectively), revealed that the FSM group (n = 55) had significantly greater increases in faecal acetate concentration compared with the SM group (n = 54) and significant upregulation of pathways related to energy production or glucose metabolism in the gut microbiota. These findings suggest that daily FSM consumption improves the gut microbiota and intestinal environment in healthy adults and may help to maintain health and prevent diseases. Registered at the University Hospital Medical Information Network (UMIN) clinical trials registry under: UMIN 000035612.Keywords
This publication has 53 references indexed in Scilit:
- Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workersEuropean Journal of Nutrition, 2015
- Towards microbial fermentation metabolites as markers for health benefits of prebioticsNutrition Research Reviews, 2015
- Effects of intestinal bacteria-derived p-cresyl sulfate on Th1-type immune response in vivo and in vitroToxicology and Applied Pharmacology, 2014
- Ultra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platformsThe ISME Journal, 2012
- Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteersThe ISME Journal, 2011
- Effects of a probiotic fermented milk beverage containing Lactobacillus casei strain Shirota on defecation frequency, intestinal microbiota, and the intestinal environment of healthy individuals with soft stoolsJournal of Bioscience and Bioengineering, 2010
- Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNAInternational Journal of Food Microbiology, 2008
- Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder CancerJournal of Urology, 2008
- Randomized trial of dietary fiber andLactobacillus casei administration for prevention of colorectal tumorsInternational Journal of Cancer, 2005
- Estimation of short-chain fatty acid production from protein by human intestinal bacteria based on branched-chain fatty acid measurementsFEMS Microbiology Letters, 1992